| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 38 | 2016 | 219 | 4.640 |
Why?
|
| Dopamine Uptake Inhibitors | 14 | 2016 | 75 | 2.340 |
Why?
|
| Proto-Oncogene Proteins c-fos | 14 | 2019 | 74 | 2.040 |
Why?
|
| Cocaine-Related Disorders | 11 | 2013 | 84 | 1.600 |
Why?
|
| Progesterone | 20 | 2010 | 117 | 1.550 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 5 | 2016 | 131 | 1.310 |
Why?
|
| Rats, Inbred F344 | 35 | 2016 | 228 | 1.290 |
Why?
|
| Sex Characteristics | 13 | 2013 | 213 | 1.290 |
Why?
|
| Rats | 59 | 2019 | 3261 | 1.220 |
Why?
|
| Corpus Striatum | 5 | 2019 | 99 | 1.210 |
Why?
|
| Caudate Nucleus | 5 | 2019 | 19 | 1.010 |
Why?
|
| Signal Transduction | 7 | 2016 | 1802 | 0.850 |
Why?
|
| Putamen | 4 | 2016 | 15 | 0.840 |
Why?
|
| Receptors, Opioid, delta | 10 | 1999 | 22 | 0.780 |
Why?
|
| Estrogens | 12 | 2015 | 190 | 0.780 |
Why?
|
| Animals | 71 | 2019 | 14307 | 0.770 |
Why?
|
| Memory | 2 | 2019 | 165 | 0.700 |
Why?
|
| RNA, Messenger | 21 | 2010 | 1152 | 0.690 |
Why?
|
| Protein Precursors | 5 | 2003 | 59 | 0.650 |
Why?
|
| Interleukin-6 | 5 | 2015 | 140 | 0.650 |
Why?
|
| Nucleus Accumbens | 7 | 2019 | 80 | 0.640 |
Why?
|
| Gene Expression Regulation | 8 | 2005 | 968 | 0.630 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 4 | 2014 | 90 | 0.620 |
Why?
|
| Behavior, Animal | 13 | 2016 | 304 | 0.610 |
Why?
|
| Methamphetamine | 1 | 2019 | 155 | 0.590 |
Why?
|
| Receptors, Dopamine D1 | 4 | 2010 | 35 | 0.590 |
Why?
|
| Conditioning, Classical | 1 | 2016 | 59 | 0.560 |
Why?
|
| Motor Activity | 14 | 2016 | 393 | 0.560 |
Why?
|
| Dizocilpine Maleate | 4 | 2016 | 45 | 0.540 |
Why?
|
| Receptors, Opioid, mu | 5 | 2002 | 47 | 0.540 |
Why?
|
| Dopamine | 3 | 2019 | 232 | 0.530 |
Why?
|
| Sertoli Cells | 4 | 2000 | 43 | 0.520 |
Why?
|
| Male | 47 | 2019 | 18870 | 0.500 |
Why?
|
| Down-Regulation | 1 | 2016 | 420 | 0.500 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 5 | 2016 | 70 | 0.500 |
Why?
|
| Estradiol | 9 | 2015 | 244 | 0.500 |
Why?
|
| Excitatory Amino Acid Antagonists | 6 | 2016 | 92 | 0.500 |
Why?
|
| Locomotion | 6 | 2016 | 91 | 0.490 |
Why?
|
| Brain | 8 | 2013 | 1268 | 0.480 |
Why?
|
| Phosphorylation | 9 | 2014 | 878 | 0.480 |
Why?
|
| Dynorphins | 2 | 2003 | 14 | 0.460 |
Why?
|
| Testosterone | 6 | 2010 | 181 | 0.460 |
Why?
|
| Ovariectomy | 16 | 2019 | 104 | 0.450 |
Why?
|
| Dopamine and cAMP-Regulated Phosphoprotein 32 | 3 | 2009 | 6 | 0.420 |
Why?
|
| Gonadal Hormones | 1 | 2012 | 6 | 0.420 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 5 | 2014 | 50 | 0.420 |
Why?
|
| Estrous Cycle | 4 | 2009 | 34 | 0.400 |
Why?
|
| Central Nervous System | 4 | 2002 | 130 | 0.400 |
Why?
|
| Rats, Sprague-Dawley | 19 | 2019 | 1534 | 0.390 |
Why?
|
| Up-Regulation | 6 | 2008 | 490 | 0.380 |
Why?
|
| Transcription Factor AP-1 | 2 | 2002 | 33 | 0.370 |
Why?
|
| Blotting, Western | 8 | 2013 | 834 | 0.360 |
Why?
|
| Pain | 7 | 2015 | 249 | 0.360 |
Why?
|
| Time Factors | 9 | 2016 | 1681 | 0.340 |
Why?
|
| Transcription, Genetic | 5 | 1998 | 550 | 0.340 |
Why?
|
| Endocrine System | 3 | 2003 | 12 | 0.330 |
Why?
|
| DNA-Binding Proteins | 5 | 2006 | 522 | 0.320 |
Why?
|
| Trans-Activators | 3 | 1998 | 167 | 0.320 |
Why?
|
| Spinal Cord | 6 | 2015 | 85 | 0.290 |
Why?
|
| Sex Factors | 7 | 2019 | 859 | 0.290 |
Why?
|
| Female | 39 | 2019 | 19873 | 0.290 |
Why?
|
| Corticosterone | 10 | 2010 | 73 | 0.280 |
Why?
|
| Interferon-gamma | 2 | 1997 | 235 | 0.280 |
Why?
|
| Cyclic AMP | 2 | 1997 | 125 | 0.270 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2002 | 50 | 0.270 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2005 | 122 | 0.260 |
Why?
|
| Anesthetics, Local | 2 | 2003 | 21 | 0.250 |
Why?
|
| Enkephalins | 5 | 1998 | 31 | 0.250 |
Why?
|
| Ethanol | 2 | 1997 | 188 | 0.240 |
Why?
|
| Genes, Immediate-Early | 2 | 2008 | 6 | 0.240 |
Why?
|
| Genes, fos | 3 | 1998 | 14 | 0.240 |
Why?
|
| Neurons | 3 | 2003 | 1130 | 0.240 |
Why?
|
| RNA | 2 | 2002 | 234 | 0.220 |
Why?
|
| Central Nervous System Stimulants | 2 | 2019 | 165 | 0.220 |
Why?
|
| Neostriatum | 1 | 2002 | 25 | 0.220 |
Why?
|
| Estrus | 2 | 2001 | 14 | 0.220 |
Why?
|
| Tretinoin | 1 | 2002 | 50 | 0.210 |
Why?
|
| Receptors, Opioid, kappa | 1 | 2000 | 15 | 0.190 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2011 | 33 | 0.190 |
Why?
|
| Astrocytes | 1 | 2002 | 203 | 0.190 |
Why?
|
| Drug Administration Schedule | 7 | 2006 | 145 | 0.190 |
Why?
|
| Cerebral Cortex | 1 | 2002 | 274 | 0.190 |
Why?
|
| Hypothalamo-Hypophyseal System | 4 | 2015 | 49 | 0.190 |
Why?
|
| Dinoprostone | 2 | 2010 | 57 | 0.180 |
Why?
|
| Formaldehyde | 5 | 2015 | 33 | 0.180 |
Why?
|
| Naltrexone | 2 | 1998 | 30 | 0.180 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2008 | 984 | 0.170 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 45 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2007 | 338 | 0.170 |
Why?
|
| Drug Interactions | 5 | 2006 | 137 | 0.170 |
Why?
|
| Substantia Nigra | 1 | 2019 | 41 | 0.170 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2019 | 72 | 0.170 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2019 | 32 | 0.170 |
Why?
|
| Lymphokines | 1 | 1998 | 11 | 0.160 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 23 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2019 | 139 | 0.160 |
Why?
|
| Pituitary-Adrenal System | 2 | 2015 | 36 | 0.150 |
Why?
|
| Dopamine Antagonists | 2 | 2008 | 39 | 0.150 |
Why?
|
| Oligopeptides | 3 | 1998 | 97 | 0.150 |
Why?
|
| Sirtuin 2 | 1 | 2016 | 2 | 0.150 |
Why?
|
| CREB-Binding Protein | 1 | 2016 | 12 | 0.150 |
Why?
|
| Testis | 1 | 1998 | 185 | 0.150 |
Why?
|
| N-Methylaspartate | 2 | 2009 | 55 | 0.150 |
Why?
|
| Globus Pallidus | 1 | 2016 | 16 | 0.150 |
Why?
|
| Sirtuin 1 | 1 | 2016 | 32 | 0.140 |
Why?
|
| Blotting, Northern | 5 | 1997 | 139 | 0.140 |
Why?
|
| Dexamethasone | 1 | 1995 | 43 | 0.130 |
Why?
|
| Ganglia, Spinal | 1 | 2015 | 36 | 0.130 |
Why?
|
| Naloxone | 1 | 1994 | 50 | 0.130 |
Why?
|
| Nociceptors | 2 | 2011 | 31 | 0.120 |
Why?
|
| Behavior | 2 | 2003 | 32 | 0.120 |
Why?
|
| Models, Animal | 2 | 2012 | 131 | 0.120 |
Why?
|
| STAT1 Transcription Factor | 3 | 1998 | 26 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2011 | 1300 | 0.110 |
Why?
|
| Stereotyped Behavior | 5 | 2008 | 20 | 0.110 |
Why?
|
| Hyperalgesia | 2 | 2011 | 15 | 0.110 |
Why?
|
| Prosencephalon | 3 | 1997 | 25 | 0.110 |
Why?
|
| Plasmids | 2 | 1995 | 233 | 0.110 |
Why?
|
| Conditioning, Operant | 1 | 2013 | 72 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 2 | 2010 | 68 | 0.110 |
Why?
|
| STAT3 Transcription Factor | 3 | 1998 | 80 | 0.110 |
Why?
|
| Inflammation | 3 | 2015 | 577 | 0.110 |
Why?
|
| Transcription Factors | 1 | 1996 | 653 | 0.100 |
Why?
|
| Cytokines | 1 | 2015 | 569 | 0.100 |
Why?
|
| DNA | 3 | 2002 | 549 | 0.100 |
Why?
|
| Cells, Cultured | 3 | 2002 | 1442 | 0.100 |
Why?
|
| Tamoxifen | 2 | 2008 | 61 | 0.090 |
Why?
|
| Progestins | 1 | 2010 | 14 | 0.090 |
Why?
|
| Binding Sites | 3 | 2003 | 597 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 112 | 0.090 |
Why?
|
| Quinpirole | 1 | 2010 | 16 | 0.090 |
Why?
|
| Dopamine Agonists | 1 | 2010 | 29 | 0.090 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 78 | 0.090 |
Why?
|
| Memory, Short-Term | 1 | 2010 | 42 | 0.090 |
Why?
|
| GTP-Binding Proteins | 1 | 2010 | 57 | 0.090 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2009 | 47 | 0.090 |
Why?
|
| DNA, Circular | 1 | 1989 | 7 | 0.090 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 126 | 0.090 |
Why?
|
| Salicylamides | 2 | 2005 | 13 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 3 | 2002 | 480 | 0.090 |
Why?
|
| Reward | 3 | 2007 | 73 | 0.090 |
Why?
|
| Simian virus 40 | 1 | 1989 | 43 | 0.090 |
Why?
|
| Tubulin | 1 | 2009 | 80 | 0.090 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2008 | 6 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2009 | 123 | 0.080 |
Why?
|
| Pregnanolone | 1 | 2008 | 3 | 0.080 |
Why?
|
| DNA Replication | 1 | 1989 | 148 | 0.080 |
Why?
|
| Hormone Antagonists | 1 | 2008 | 15 | 0.080 |
Why?
|
| Neuroblastoma | 2 | 2002 | 128 | 0.080 |
Why?
|
| Mifepristone | 1 | 2008 | 33 | 0.080 |
Why?
|
| Transfection | 1 | 1989 | 496 | 0.080 |
Why?
|
| Mice | 10 | 2003 | 5668 | 0.080 |
Why?
|
| Genistein | 2 | 1998 | 41 | 0.080 |
Why?
|
| DNA, Viral | 1 | 1989 | 295 | 0.080 |
Why?
|
| Biogenic Monoamines | 2 | 2004 | 30 | 0.080 |
Why?
|
| Pain Measurement | 4 | 2010 | 161 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 2 | 1997 | 38 | 0.070 |
Why?
|
| Enzyme Induction | 1 | 2005 | 48 | 0.070 |
Why?
|
| Pain Threshold | 1 | 2005 | 24 | 0.070 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 52 | 0.070 |
Why?
|
| Benzazepines | 1 | 2005 | 29 | 0.070 |
Why?
|
| Animals, Newborn | 2 | 2003 | 323 | 0.060 |
Why?
|
| Analysis of Variance | 4 | 2008 | 528 | 0.060 |
Why?
|
| Posterior Horn Cells | 1 | 2003 | 2 | 0.060 |
Why?
|
| Dextromethorphan | 1 | 2003 | 3 | 0.060 |
Why?
|
| Morphine Dependence | 1 | 2003 | 25 | 0.060 |
Why?
|
| Enzyme Inhibitors | 2 | 2011 | 396 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2011 | 171 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2002 | 63 | 0.050 |
Why?
|
| Hormones | 1 | 2002 | 51 | 0.050 |
Why?
|
| Exploratory Behavior | 3 | 2010 | 72 | 0.050 |
Why?
|
| In Situ Hybridization | 6 | 1997 | 125 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 103 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2002 | 859 | 0.050 |
Why?
|
| Gonads | 1 | 2001 | 20 | 0.050 |
Why?
|
| Humans | 4 | 2012 | 34853 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2001 | 50 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2000 | 5 | 0.050 |
Why?
|
| Dactinomycin | 1 | 2000 | 12 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2000 | 5 | 0.050 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2000 | 20 | 0.050 |
Why?
|
| Cycloheximide | 1 | 2000 | 30 | 0.050 |
Why?
|
| Base Sequence | 3 | 1997 | 932 | 0.050 |
Why?
|
| Adrenalectomy | 2 | 2015 | 24 | 0.050 |
Why?
|
| Drug Tolerance | 2 | 2016 | 38 | 0.040 |
Why?
|
| Ovary | 2 | 1996 | 101 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 562 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 605 | 0.040 |
Why?
|
| Receptors, OSM-LIF | 1 | 1998 | 1 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 1998 | 1 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 1998 | 3 | 0.040 |
Why?
|
| Reaction Time | 3 | 2006 | 130 | 0.040 |
Why?
|
| 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 1998 | 6 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1995 | 67 | 0.040 |
Why?
|
| Receptors, Cytokine | 1 | 1998 | 11 | 0.040 |
Why?
|
| Narcotic Antagonists | 1 | 1998 | 50 | 0.040 |
Why?
|
| Genes, jun | 1 | 1997 | 7 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 23 | 0.040 |
Why?
|
| Analgesics | 1 | 1998 | 56 | 0.040 |
Why?
|
| Threonine | 1 | 1997 | 21 | 0.040 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1998 | 117 | 0.040 |
Why?
|
| Serine | 1 | 1997 | 72 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 1999 | 176 | 0.040 |
Why?
|
| Tyrosine | 1 | 1997 | 109 | 0.040 |
Why?
|
| Receptors, Oxytocin | 1 | 1997 | 8 | 0.040 |
Why?
|
| Pituitary Gland | 1 | 1997 | 59 | 0.040 |
Why?
|
| Acute-Phase Proteins | 1 | 1996 | 14 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 2016 | 8 | 0.040 |
Why?
|
| Transcriptional Activation | 1 | 1997 | 164 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1996 | 52 | 0.040 |
Why?
|
| Uterus | 1 | 1997 | 54 | 0.040 |
Why?
|
| Receptors, LHRH | 1 | 1996 | 2 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1996 | 10 | 0.040 |
Why?
|
| Phosphotransferases | 1 | 2016 | 35 | 0.040 |
Why?
|
| Isoflavones | 1 | 1997 | 125 | 0.040 |
Why?
|
| Spermatozoa | 1 | 1998 | 191 | 0.040 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1996 | 6 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 1996 | 10 | 0.040 |
Why?
|
| Enkephalin, Methionine | 1 | 1995 | 7 | 0.030 |
Why?
|
| Nerve Endings | 1 | 1995 | 8 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2008 | 66 | 0.030 |
Why?
|
| Injections, Intraperitoneal | 2 | 2008 | 58 | 0.030 |
Why?
|
| Castration | 2 | 2008 | 33 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 51 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1995 | 22 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1995 | 31 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 1995 | 52 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 485 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 310 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 1994 | 19 | 0.030 |
Why?
|
| Hormone Replacement Therapy | 2 | 2006 | 41 | 0.030 |
Why?
|
| Axons | 1 | 1995 | 106 | 0.030 |
Why?
|
| RNA, Neoplasm | 1 | 1994 | 25 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 1996 | 351 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2015 | 69 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 66 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 287 | 0.030 |
Why?
|
| Models, Molecular | 1 | 1997 | 751 | 0.030 |
Why?
|
| Acute Disease | 2 | 2003 | 141 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 325 | 0.030 |
Why?
|
| Injections, Intraventricular | 3 | 1998 | 60 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 484 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 1994 | 203 | 0.030 |
Why?
|
| Mice, Inbred Strains | 3 | 1997 | 117 | 0.030 |
Why?
|
| Irritants | 1 | 2011 | 8 | 0.030 |
Why?
|
| Carrageenan | 1 | 2011 | 10 | 0.030 |
Why?
|
| Sesame Oil | 1 | 2010 | 2 | 0.020 |
Why?
|
| Guanosine 5'-O-(3-Thiotriphosphate) | 1 | 2010 | 6 | 0.020 |
Why?
|
| Autoradiography | 1 | 2010 | 36 | 0.020 |
Why?
|
| Cyclooxygenase 1 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2010 | 103 | 0.020 |
Why?
|
| Motor Skills | 1 | 2010 | 25 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 1997 | 756 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 423 | 0.020 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2010 | 44 | 0.020 |
Why?
|
| Receptors, Neuropeptide Y | 1 | 2009 | 8 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2010 | 92 | 0.020 |
Why?
|
| Haplorhini | 1 | 1989 | 21 | 0.020 |
Why?
|
| Sexual Behavior, Animal | 2 | 2002 | 51 | 0.020 |
Why?
|
| Camptothecin | 1 | 1989 | 20 | 0.020 |
Why?
|
| Calcineurin | 1 | 2008 | 21 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1989 | 186 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1989 | 90 | 0.020 |
Why?
|
| Protein Phosphatase 1 | 1 | 2008 | 58 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1989 | 142 | 0.020 |
Why?
|
| Prefrontal Cortex | 1 | 2010 | 133 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 1995 | 1490 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2010 | 287 | 0.020 |
Why?
|
| Menstrual Cycle | 1 | 2007 | 34 | 0.020 |
Why?
|
| Recurrence | 1 | 2007 | 125 | 0.020 |
Why?
|
| Memory Disorders | 1 | 2007 | 65 | 0.020 |
Why?
|
| Enkephalin, D-Penicillamine (2,5)- | 2 | 1998 | 7 | 0.020 |
Why?
|
| Learning | 1 | 2007 | 108 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 255 | 0.020 |
Why?
|
| Receptors, Steroid | 1 | 2006 | 33 | 0.020 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2006 | 58 | 0.020 |
Why?
|
| Cognition | 1 | 2010 | 373 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 486 | 0.020 |
Why?
|
| Analgesia | 1 | 2005 | 20 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2005 | 26 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 106 | 0.020 |
Why?
|
| Cell Line | 1 | 1989 | 1289 | 0.020 |
Why?
|
| RNA Probes | 2 | 1995 | 10 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2003 | 19 | 0.010 |
Why?
|
| Dependovirus | 1 | 2003 | 11 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2003 | 14 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 27 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2003 | 78 | 0.010 |
Why?
|
| Introns | 1 | 2003 | 67 | 0.010 |
Why?
|
| Receptors, AMPA | 1 | 2003 | 54 | 0.010 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2003 | 75 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 2003 | 154 | 0.010 |
Why?
|
| Patch-Clamp Techniques | 1 | 2003 | 214 | 0.010 |
Why?
|
| Ventral Tegmental Area | 1 | 2003 | 36 | 0.010 |
Why?
|
| Morphine | 1 | 2003 | 80 | 0.010 |
Why?
|
| Cesarean Section | 1 | 2003 | 53 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1995 | 1124 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2003 | 141 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 172 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2003 | 406 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 639 | 0.010 |
Why?
|
| Periaqueductal Gray | 1 | 1997 | 9 | 0.010 |
Why?
|
| Thalamus | 1 | 1997 | 29 | 0.010 |
Why?
|
| Frontal Lobe | 1 | 1997 | 49 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1997 | 123 | 0.010 |
Why?
|
| Hypothalamus, Middle | 1 | 1997 | 3 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 650 | 0.010 |
Why?
|
| Chloral Hydrate | 1 | 1996 | 1 | 0.010 |
Why?
|
| Pentobarbital | 1 | 1996 | 2 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 233 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 21 | 0.010 |
Why?
|
| Amygdala | 1 | 1997 | 110 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1996 | 202 | 0.010 |
Why?
|
| Immune Sera | 1 | 1995 | 59 | 0.010 |
Why?
|
| Neck | 1 | 1995 | 20 | 0.010 |
Why?
|
| Dendrites | 1 | 1995 | 52 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1995 | 105 | 0.010 |
Why?
|
| Drug Stability | 1 | 1995 | 110 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 197 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 204 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1996 | 608 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 175 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 430 | 0.010 |
Why?
|
| Linear Models | 1 | 1995 | 253 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1995 | 282 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1995 | 555 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 1995 | 298 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 1995 | 901 | 0.010 |
Why?
|